Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Enalapril maleate and a lysine analogue (MK-521): disposition in man.
|
Br J Clin Pharmacol
|
1982
|
2.49
|
2
|
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
|
Br J Clin Pharmacol
|
1982
|
1.95
|
3
|
Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers.
|
Biopharm Drug Dispos
|
1984
|
1.37
|
4
|
Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
|
Clin Pharmacol Ther
|
1982
|
1.28
|
5
|
The effect of renal function on enalapril kinetics.
|
Clin Pharmacol Ther
|
1985
|
1.15
|
6
|
The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure.
|
Br J Clin Pharmacol
|
1987
|
1.05
|
7
|
Specific cleavage of the A1 protein from myelin with cathepsin D.
|
J Biol Chem
|
1974
|
0.95
|
8
|
Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.
|
Endocrinology
|
1981
|
0.94
|
9
|
Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro.
|
Res Commun Chem Pathol Pharmacol
|
1981
|
0.92
|
10
|
Control of the LH receptor by prolactin and prostaglandin F2alpha in rat corpora lutea.
|
Biol Reprod
|
1976
|
0.89
|
11
|
Initial evaluation of transdermal timolol: serum concentrations and beta-blockade.
|
J Cardiovasc Pharmacol
|
1985
|
0.88
|
12
|
The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results.
|
Mov Disord
|
1989
|
0.86
|
13
|
Binding of human chorionic gonadotropin and response of cyclic nucleotides to luteinizing hormone in luteal tissue from rats treated with prostaglandin F2alpha.
|
Endocrinology
|
1976
|
0.82
|
14
|
Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.
|
Neurology
|
1989
|
0.81
|
15
|
Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.
|
J Neurol Neurosurg Psychiatry
|
1989
|
0.80
|
16
|
Rapid block of gonadotropin uptake by corpora lutea in vivo induced by prostaglandin F2alpha.
|
Prostaglandins
|
1976
|
0.80
|
17
|
Quantitative autoradiographic determination of angiotensin-converting enzyme (kininase II) binding in individual rat brain nuclei with 125I-351A, a specific enzyme inhibitor.
|
Brain Res
|
1985
|
0.79
|
18
|
PGF-2 alpha-induced loss of corpus luteum gonadotrophin receptors.
|
Prostaglandins
|
1974
|
0.79
|
19
|
Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates.
|
Brain Res
|
1991
|
0.78
|
20
|
Renal handling of alendronate in rats. An uncharacterized renal transport system.
|
Drug Metab Dispos
|
1992
|
0.78
|
21
|
Pharmacokinetics of orally administered ciprofloxacin in abdominal surgery.
|
Am J Med
|
1989
|
0.78
|
22
|
Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.
|
J Pharmacol Exp Ther
|
1993
|
0.77
|
23
|
Biological activities of a new steroidal inhibitor of delta 4-5 alpha-reductase.
|
Proc Soc Exp Biol Med
|
1982
|
0.77
|
24
|
Radioimmunoassay for dexamethasone in plasma.
|
Clin Chem
|
1974
|
0.77
|
25
|
Inhibitor binding assay for angiotensin-converting enzyme.
|
Clin Chem
|
1984
|
0.77
|
26
|
In vivo and in vitro metabolism studies on a class III antiarrhythmic agent.
|
Drug Metab Dispos
|
1993
|
0.77
|
27
|
The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure.
|
Br J Clin Pharmacol
|
1989
|
0.77
|
28
|
A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.
|
Drug Metab Rev
|
1983
|
0.76
|
29
|
Studies on the mechanism of PGF2alpha and gonadotropin interactions on LH receptor function in corpora lutea during luteolysis.
|
Adv Prostaglandin Thromboxane Res
|
1976
|
0.76
|
30
|
Effect of hypophysectomy, prolactin, and prostaglandin F2 alpha on gonadotropin binding in vivo and in vitro in the corpus luteum.
|
Endocrinology
|
1978
|
0.76
|
31
|
Chemistry and biochemistry of the neomycins. XVII. Bioconversion of aminocyclitols to aminocyclitol antibiotics.
|
J Antibiot (Tokyo)
|
1973
|
0.76
|
32
|
Comment on Huttunen K, Grönhagen-Riska C and Fyhrquist F, 1989. Enalapril treatment of a nursing mother with slightly impaired renal function. Clin Nephrol 31: 278.
|
Clin Nephrol
|
1991
|
0.75
|
33
|
The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid.
|
J Infect
|
1993
|
0.75
|
34
|
The effect of enalapril on serum prolactin.
|
Br J Clin Pharmacol
|
1983
|
0.75
|
35
|
Pharmacokinetics of lisinopril (IV/PO) in healthy volunteers.
|
Biopharm Drug Dispos
|
1989
|
0.75
|
36
|
An acute allergic inflammation in the rat.
|
J Pathol
|
1970
|
0.75
|
37
|
Analysis of sulindac and metabolites by combined isotope dilution-radioimmunoassay.
|
J Pharm Sci
|
1977
|
0.75
|
38
|
Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay.
|
J Pharm Biomed Anal
|
1993
|
0.75
|
39
|
Chemical inhibition of estrus in the beagle.
|
Theriogenology
|
1976
|
0.75
|
40
|
Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humans.
|
Fed Proc
|
1984
|
0.75
|
41
|
Serum profiles of luteinizing hormone, progesterone and total estrogens during the canine estrous cycle.
|
Theriogenology
|
1976
|
0.75
|
42
|
Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate.
|
Arch Intern Med
|
1986
|
0.75
|
43
|
Radioimmunoassays for the enantiomeric components of indacrinone and their phenolic metabolites.
|
J Immunoassay
|
1987
|
0.75
|
44
|
Determination of L-691,121, a new class III antiarrhythmic, and its principal metabolite in plasma by differential radioimmunoassay.
|
J Pharm Biomed Anal
|
1994
|
0.75
|
45
|
Metabolism of antiparkinson agent dopazinol by rat liver microsomes.
|
Drug Metab Dispos
|
1991
|
0.75
|
46
|
L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems.
|
J Pharmacol Exp Ther
|
1984
|
0.75
|
47
|
Antibiotic prophylaxis in cardiac surgery: factors associated with potentially toxic serum concentrations of gentamicin.
|
J Antimicrob Chemother
|
1995
|
0.75
|
48
|
Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay.
|
J Pharm Biomed Anal
|
1994
|
0.75
|
49
|
Studies of a glycoprotein in the oocysts of Eimeria tenella.
|
J Biol Chem
|
1976
|
0.75
|
50
|
Clearance of gentamicin during cardiac surgery.
|
J Antimicrob Chemother
|
1995
|
0.75
|